ibrutinib
janssen,abbvie
['ibru', 'cll']
intriguing results with fixed duration ibrutinib &amp; ven for #cllsm ! anyone using this approach already? #asco22 #mediq22asco 
Director-Heme Early Therapeutics & Leader-Leukemia/Myeloid Research @Yale. Personal views. I tweet on cancer, travel, food & soccer. COI: https://t.co/6XkF8CmtrK